GO:1990570 GDP-mannose transmembrane transport: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990570 GDP-mannose transmembrane transport describes the process in which GDP-mannose is transported across a membrane, typically into the Golgi lumen for glycosylation reactions.
• The best-characterized transporters are Golgi-localized proteins such as Vrg4 in Saccharomyces cerevisiae and its orthologs in Schizosaccharomyces pombe and Cryptococcus neoformans.
• GDP-mannose transporters are essential for mannan and mannoprotein biosynthesis, cell wall integrity, and virulence in fungal pathogens.
• Localization of the transporter to the Golgi requires retrieval to the endoplasmic reticulum, dependent on its cytoplasmic tail and coatomer (COPI).
• In plants, GDP-mannose transport is linked to the biosynthesis of vitamin C (L-ascorbic acid) via the Smirnoff-Wheeler pathway.
• Studying GDP-mannose transmembrane transport requires combining genetic, biochemical, and imaging approaches; CRISPR-based models enable precise interrogation of transporter function.
Description
GDP-mannose transmembrane transport (GO:1990570) is the biological process by which the nucleotide sugar GDP-mannose is moved across a membrane. This process is fundamental for delivering activated mannose donors into the lumen of the secretory pathway, where they serve as substrates for mannosyltransferases that build mannans, mannoproteins, and glycosylphosphatidylinositol (GPI) anchors. In fungi, GDP-mannose transporters are critical for cell wall biosynthesis and virulence, making them potential antifungal targets. In plants, GDP-mannose transport contributes to the biosynthesis of vitamin C through the Smirnoff-Wheeler pathway, highlighting its broader metabolic importance. Researchers studying this process aim to understand how nucleotide sugar transporters (NSTs) maintain substrate specificity, how they are localized and regulated, and how their dysfunction affects cellular physiology and disease. The Golgi GDP-mannose transporter Vrg4 in Saccharomyces cerevisiae was the first to be molecularly characterized, and subsequent studies identified dual transporters in Cryptococcus neoformans and a valproic acid-sensitive mutant in Schizosaccharomyces pombe. These findings underscore the evolutionary conservation and functional diversity of GDP-mannose transport across species.
GDP-mannose transmembrane transport At A Glance
| GO ID | GO:1990570 |
|---|---|
| GO term | GDP-mannose transmembrane transport |
| Ontology | biological_process |
| Synonym | GDP-mannose transport |
| Major function | Transport of GDP-mannose across cellular membranes, typically into the Golgi lumen for glycosylation |
| Key transporters | Vrg4 (S. cerevisiae), Vrg4 orthologs in S. pombe and C. neoformans |
| Cellular location | Golgi apparatus membrane, with retrieval to ER via COPI vesicles |
| Associated processes | Mannan biosynthesis, GPI anchor synthesis, vitamin C biosynthesis in plants |
What Is GO:1990570?
According to the Gene Ontology, GO:1990570 GDP-mannose transmembrane transport is defined as the process in which GDP-mannose is transported across a membrane. This transport typically occurs from the cytosol into the lumen of the Golgi apparatus or endoplasmic reticulum, mediated by specific transmembrane transporter proteins. The process is distinct from simple diffusion and often requires energy or coupling to other transport events, although the exact mechanism may vary by organism and transporter.
Why Is GDP-mannose transmembrane transport Important in Cell Biology?
GDP-mannose transmembrane transport is essential for the biosynthesis of mannose-containing glycoconjugates, which are critical for cell wall integrity, protein glycosylation, and host-pathogen interactions in fungi. In plants, it supplies GDP-mannose for the production of vitamin C, a vital antioxidant and enzyme cofactor. Defects in this transport process can lead to impaired glycosylation, reduced virulence, and altered drug sensitivity, as shown by the valproic acid-sensitive phenotype of a S. pombe vrg4 mutant. Understanding this process provides insights into fundamental cell biology and offers potential targets for antifungal and therapeutic development.
• Essential for mannan and mannoprotein biosynthesis in fungal cell walls.
• Required for GPI anchor synthesis and protein sorting in eukaryotes.
• Contributes to vitamin C biosynthesis in plants via the Smirnoff-Wheeler pathway.
• Influences fungal virulence and drug susceptibility, as shown in Cryptococcus neoformans and Schizosaccharomyces pombe.
• Provides a model for studying nucleotide sugar transporter (NST) specificity and regulation.
• Linked to Golgi homeostasis and COPI-mediated retrieval of membrane proteins.
• Potential target for antifungal drugs due to its role in cell wall synthesis.
• Relevant to congenital disorders of glycosylation when orthologous transport is disrupted.
• Important for understanding plant ascorbate metabolism and stress responses.
• Enables comparative studies of glycosylation pathways across species.
What Happens During GDP-mannose transmembrane transport?
Synthesis and cytosolic availability of GDP-mannose
In simple terms: GDP-mannose is made in the cytosol before it can be transported.
GDP-mannose is synthesized in the cytosol from mannose-1-phosphate and GTP by the enzyme GDP-mannose pyrophosphorylase (also known as Psa1 in yeast or VTC1 in plants). This nucleotide sugar is then available for transport into the secretory pathway. In plants, the same pathway supplies GDP-mannose for vitamin C biosynthesis, linking cytosolic synthesis to downstream transport.
Recognition and binding by the Golgi transporter
In simple terms: The transporter protein in the Golgi membrane grabs GDP-mannose and prepares to move it across.
The Golgi GDP-mannose transporter, such as Vrg4 in Saccharomyces cerevisiae, is a multi-spanning membrane protein that specifically binds GDP-mannose on its cytosolic side. Mutational analysis has identified residues critical for substrate recognition and transport activity. The transporter is thought to undergo conformational changes to shuttle the nucleotide sugar across the lipid bilayer.
Translocation across the Golgi membrane
In simple terms: GDP-mannose is moved through the transporter into the Golgi lumen.
Once bound, GDP-mannose is translocated across the Golgi membrane into the lumen, where it is released for use by mannosyltransferases. This transport is likely coupled to a counter-exchange mechanism, although the exact stoichiometry remains to be fully defined. In Cryptococcus neoformans, two GDP-mannose transporters (Gmt1 and Gmt2) function redundantly to ensure sufficient luminal GDP-mannose for capsule and cell wall synthesis.
Retrieval and localization of the transporter
In simple terms: The transporter is recycled back to the ER to maintain proper Golgi localization.
Localization of the GDP-mannose transporter in the Golgi requires retrieval to the endoplasmic reticulum, depending on its cytoplasmic tail and coatomer (COPI). This retrieval mechanism ensures that the transporter cycles between the ER and Golgi and maintains steady-state levels in the Golgi. Disruption of this retrieval leads to mislocalization and impaired transport.
Utilization of luminal GDP-mannose
In simple terms: Once inside the Golgi, GDP-mannose is used to build sugar chains on proteins and lipids.
In the Golgi lumen, GDP-mannose serves as a substrate for mannosyltransferases that elongate mannan chains on proteins and lipids, including GPI anchors. This process is essential for cell wall integrity and protein function. In Toxoplasma gondii, GPI anchor biosynthesis depends on the availability of GDP-mannose, highlighting the conserved role of this transport step.
Key Genes Involved in GO:1990570 GDP-mannose transmembrane transport
The following genes and proteins are directly implicated in GDP-mannose transmembrane transport or its regulation, based on published experimental evidence.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VRG4 (S. cerevisiae) | Golgi GDP-mannose transporter | First molecularly characterized GDP-mannose transporter; essential for mannan synthesis |
| vrg4+ (S. pombe) | Golgi GDP-mannose transporter | Valproic acid-sensitive mutant allele links transport to drug response |
| GMT1 (C. neoformans) | GDP-mannose transporter | Dual transporter with GMT2; required for virulence |
| GMT2 (C. neoformans) | GDP-mannose transporter | Redundant with GMT1; contributes to cell wall integrity |
| VTC1 (Arabidopsis) | GDP-mannose pyrophosphorylase | Synthesizes GDP-mannose for vitamin C pathway |
| GmtA (Aspergillus niger) | UDP-galactofuranose transporter | Related NST; helps understand transporter specificity |
| GmtB (Aspergillus niger) | UDP-galactofuranose transporter | Overlapping function with GmtA |
| Efr3 (Drosophila) | Gap junction transfer of GDP-L-fucose | Shows nucleotide sugar transfer between cells |
| TgGPI (Toxoplasma gondii) | GPI anchor biosynthesis | Requires GDP-mannose for GPI mannosylation |
| COPI subunits | Retrieval of Vrg4 to ER | Regulates Golgi localization of GDP-mannose transporter |
| Psa1 (S. cerevisiae) | GDP-mannose pyrophosphorylase | Provides substrate for Vrg4 |
| Vrg4 orthologs in fungi | GDP-mannose transport | Potential antifungal targets |
| Golgi mannosyltransferases | Utilize luminal GDP-mannose | Downstream effectors of transport |
| GPI mannosyltransferases | GPI anchor synthesis | Depend on GDP-mannose transport |
| Notch signaling components | GDP-L-fucose transport | Related nucleotide sugar transport in Drosophila |
How Is GDP-mannose transmembrane transport Regulated?
The regulation of GDP-mannose transmembrane transport is not fully understood, but evidence suggests that transporter localization and activity are controlled by COPI-mediated retrieval and potentially by substrate availability. In Schizosaccharomyces pombe, a mutation in the vrg4 gene confers sensitivity to valproic acid, indicating that transport activity can be modulated by small molecules. Additionally, the expression of dual transporters in Cryptococcus neoformans may be differentially regulated to meet metabolic demands during infection. Further studies are needed to identify specific transcriptional or post-translational regulators.
GDP-mannose transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GMT1/GMT2 (C. neoformans) | Cryptococcosis virulence | Mouse infection model with double knockout |
| vrg4 (S. pombe) | Valproic acid sensitivity | Spot assays and growth inhibition |
| VRG4 (S. cerevisiae) | Cell wall integrity defects | Temperature-sensitive mutants and osmotic support |
| VTC1 (Arabidopsis) | Vitamin C deficiency | Knockout plants and ascorbate measurements |
| TgGPI (T. gondii) | GPI anchor deficiency | Parasite growth and host cell invasion assays |
Fungal infections and virulence
GDP-mannose transporters are critical for the virulence of Cryptococcus neoformans, as deletion of both GMT1 and GMT2 attenuates the pathogen in animal models. The transporter is required for capsule and cell wall mannan synthesis, which are key virulence factors. Inhibiting GDP-mannose transport could therefore be a therapeutic strategy against cryptococcosis.
Drug sensitivity and resistance
A valproic acid-sensitive mutant allele of the Golgi GDP-mannose transporter Vrg4 in Schizosaccharomyces pombe links transport function to drug response. This suggests that alterations in GDP-mannose transport may modulate susceptibility to certain drugs, with potential implications for antifungal therapy.
Congenital disorders of glycosylation
While direct human diseases linked to GDP-mannose transmembrane transport are not well documented, defects in related nucleotide sugar transporters cause congenital disorders of glycosylation (CDGs). Understanding the fungal and plant orthologs may provide insights into human NST-related pathologies.
Plant vitamin C deficiency
In plants, disruption of GDP-mannose supply for the Smirnoff-Wheeler pathway leads to reduced vitamin C levels, affecting stress tolerance and development. This highlights the importance of GDP-mannose transport in plant physiology and nutrition.
From GDP-mannose transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of GDP-mannose transporter knockout on cell viability? | CRISPR knockout in S. cerevisiae or C. neoformans |
| How does a point mutation affect transporter activity and drug sensitivity? | CRISPR point mutation in S. pombe vrg4 |
| Can a tagged transporter be used to study localization? | Knock-in of GFP tag at the endogenous locus |
| What happens when the transporter is overexpressed? | Overexpression plasmid or CRISPR activation |
| Which genes are regulated by GDP-mannose transport? | RNA-seq after transporter knockout |
| How does transport affect protein glycosylation? | Proteomics and glycomics in mutant strains |
How to Study the GDP-mannose transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of transporter function | Assess cell viability and virulence |
| CRISPR point mutation | Specific amino acid changes | Study drug sensitivity and transport activity |
| GFP knock-in | Protein localization | Live-cell imaging of Golgi dynamics |
| In vitro transport assay | GDP-mannose uptake | Measure kinetics and specificity |
| RNA-seq | Transcriptional changes | Identify compensatory pathways |
| Proteomics | Protein abundance and modifications | Assess glycosylation defects |
| Glycomics | Mannan structure | Analyze cell wall composition |
| Virulence assays | Pathogenicity in animal models | Test antifungal targets |
Genetic approaches
Classical genetics and CRISPR-based editing are used to create knockout, point mutant, and tagged alleles of GDP-mannose transporter genes. These models allow researchers to assess the effects of loss or alteration of transport on cell growth, drug sensitivity, and virulence.
Biochemical assays
In vitro transport assays using Golgi-enriched membranes or reconstituted proteoliposomes can measure GDP-mannose uptake. Such assays help determine substrate specificity, kinetics, and the effect of mutations.
Imaging and localization
Fluorescence microscopy of GFP-tagged transporters is used to study subcellular localization and retrieval to the ER. Co-localization with Golgi markers confirms proper targeting.
Omics and systems biology
Transcriptomics (RNA-seq) and proteomics can reveal global changes in gene expression and protein glycosylation upon disruption of GDP-mannose transport. These approaches help identify downstream pathways and compensatory mechanisms.
How CRISPR Can Be Used to Study GO:1990570 GDP-mannose transmembrane transport
Knockout
CRISPR knockout of GDP-mannose transporter genes, such as GMT1 and GMT2 in Cryptococcus neoformans, has been used to demonstrate their essential role in virulence and cell wall integrity. In Saccharomyces cerevisiae, VRG4 knockout is lethal, but conditional mutants have been generated to study its function.
Point Mutation
CRISPR point mutation can introduce specific amino acid substitutions in the transporter to dissect substrate binding and drug sensitivity. For example, a valproic acid-sensitive allele of vrg4 in Schizosaccharomyces pombe was characterized using such approaches.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at the endogenous locus allows real-time visualization of transporter trafficking and localization. This approach has been used to study the retrieval of Vrg4 from the Golgi to the ER.
Overexpression
Overexpression of GDP-mannose transporters can be achieved via CRISPR activation or plasmid-based systems to study gain-of-function phenotypes, such as increased mannan synthesis or altered drug resistance.
How EDITGENE Supports GDP-mannose transmembrane transport Research
Researchers studying GDP-mannose transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in glycosylation, cell wall integrity, or virulence. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for GDP-mannose transmembrane transport research.
Frequently Asked Questions About GDP-mannose transmembrane transport
What is GDP-mannose transmembrane transport?
It is the process of moving GDP-mannose across a membrane, typically into the Golgi lumen, as defined by GO:1990570.
What genes are involved in GDP-mannose transmembrane transport?
Key genes include VRG4 in Saccharomyces cerevisiae, vrg4+ in Schizosaccharomyces pombe, and GMT1/GMT2 in Cryptococcus neoformans.
Why is GDP-mannose transport important for fungi?
It is essential for mannan and mannoprotein biosynthesis, cell wall integrity, and virulence.
How is the GDP-mannose transporter localized?
It localizes to the Golgi and is retrieved to the ER via COPI-dependent mechanisms involving its cytoplasmic tail.
What diseases are linked to GDP-mannose transport?
Fungal infections such as cryptococcosis, and potentially congenital disorders of glycosylation.
Can CRISPR be used to study GDP-mannose transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful tools for functional studies.
What is the role of GDP-mannose transport in plants?
It supplies GDP-mannose for vitamin C biosynthesis via the Smirnoff-Wheeler pathway.
How can I measure GDP-mannose transport activity?
In vitro transport assays using Golgi membranes or proteoliposomes can measure uptake.
What are the model organisms for studying GDP-mannose transport?
Saccharomyces cerevisiae, Schizosaccharomyces pombe, Cryptococcus neoformans, and Arabidopsis thaliana.
What services does EDITGENE offer for GDP-mannose transport research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
GDP-mannose transmembrane transport (GO:1990570) is a fundamental biological process that delivers the nucleotide sugar GDP-mannose into the secretory pathway for glycosylation. Its importance spans fungal cell wall biosynthesis, virulence, plant vitamin C production, and potentially human glycosylation disorders. The characterized transporters, such as Vrg4 and its orthologs, provide valuable models for studying nucleotide sugar transport mechanisms and regulation. With advanced CRISPR tools and EDITGENE services, researchers can precisely manipulate these genes to uncover new insights and develop therapeutic strategies.
References
- 1. Takasaki T et al.. 2024. Characterization of a valproic acid-sensitive mutant allele of the Golgi GDP-mannose transmembrane transporter Vrg4 in Schizosaccharomyces pombe.. MicroPubl Biol 2024 PMID: 39247787
- 2. Wang ZA et al.. 2014. Cryptococcus neoformans dual GDP-mannose transporters and their role in biology and virulence.. Eukaryot Cell 13(6):832-42 PMID: 24747214
- 3. Abe M et al.. 1999. Molecular characterization of Vig4/Vrg4 GDP-mannose transporter of the yeast Saccharomyces cerevisiae.. FEBS Lett 458(3):309-12 PMID: 10570930
- 4. Abe M et al.. 2004. Localization of GDP-mannose transporter in the Golgi requires retrieval to the endoplasmic reticulum depending on its cytoplasmic tail and coatomer.. J Cell Sci 117(Pt 23):5687-96 PMID: 15494368
- 5. Wheeler GL et al.. 1998. The biosynthetic pathway of vitamin C in higher plants.. Nature 393(6683):365-9 PMID: 9620799
- 6. Park J et al.. 2015. Identification and functional analysis of two Golgi-localized UDP-galactofuranose transporters with overlapping functions in Aspergillus niger.. BMC Microbiol 15:253 PMID: 26526354
- 7. Ayukawa T et al.. 2012. Rescue of Notch signaling in cells incapable of GDP-L-fucose synthesis by gap junction transfer of GDP-L-fucose in Drosophila.. Proc Natl Acad Sci U S A 109(38):15318-23 PMID: 22949680
- 8. Kimmel J et al.. 2006. Membrane topology and transient acylation of Toxoplasma gondii glycosylphosphatidylinositols.. Eukaryot Cell 5(8):1420-9 PMID: 16896225
